mortality data
[대역어] 사망률 데이터
[용어속성] Term
[용어속성] Term
Solar UV-B/A radiation is highly effective in inactivating SARS-CoV-2
Article
[키워드] Atmospheric science
average
characteristic
Concentration
diffusion
earth
effective
Epidemics
Epidemiology
intensity
less
lower mortality
Mortality
mortality data
outbreak
Pandemics
Radiation
recorded
Region
SARS-CoV-2
single-stranded RNA virus
Single-stranded RNA viruses
Solar
Solar physics
TCID
the SARS-CoV-2
UV light
virion
virucidal
virus
viruses
[DOI] 10.1038/s41598-021-94417-9 PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41598-021-94417-9 PMC 바로가기 [Article Type] Article
Estimating the wave 1 and wave 2 infection fatality rates from SARS-CoV-2 in India
Research Note
[키워드] available data
Case fatality rate
Council
COVID-19 infection
CrI
death
deaths
estimate
estimates
excess deaths
Factors
False negative rates
Fatality rate
First wave
IFR
India
Infection
intrinsically
mortality data
National
objective
released
reported
Result
RT-PCR test
SARS-CoV-2
second wave
SEIR model
Serosurvey
supplementary material
Taking
Underreporting
Variation
yielding
[DOI] 10.1186/s13104-021-05652-2 PMC 바로가기 [Article Type] Research Note
[DOI] 10.1186/s13104-021-05652-2 PMC 바로가기 [Article Type] Research Note
Estimating the wave 1 and wave 2 infection fatality rates from SARS-CoV-2 in India
Research Note
[키워드] available data
Case fatality rate
Council
COVID-19 infection
CrI
death
deaths
estimate
estimates
excess deaths
Factors
False negative rates
Fatality rate
First wave
IFR
India
Infection
intrinsically
mortality data
National
objective
released
reported
Result
RT-PCR test
SARS-CoV-2
second wave
SEIR model
Serosurvey
supplementary material
Taking
Underreporting
Variation
yielding
[DOI] 10.1186/s13104-021-05652-2 PMC 바로가기 [Article Type] Research Note
[DOI] 10.1186/s13104-021-05652-2 PMC 바로가기 [Article Type] Research Note
Estimating the Cumulative Incidence of SARS-CoV-2 Infection and the Infection Fatality Ratio in Light of Waning Antibodies
항체 감소에 따른 SARS-CoV-2 감염 누적 발생률 및 감염 치사율 추정
Article
[키워드] acquisition
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
adjust
antibodies
antibody
approach
average
Connecticut
coronavirus
credible interval
cross-sectional
cumulative
cumulative incidence
declined
detectable
estimate
estimation
expected
expected levels
facilitate
fatality
help
identify
IFR
Immunoglobulin
immunoglobulins
incidence
Infection
infections
LIGHT
magnitude
measure
mortality data
New York City
protective immunity
Ratio
reached
reported
respiratory
SARS-CoV-2
SARS-COV-2 infection
Seroconversion
serologic assay
serologic assays
serology
serology tests
seroreversion
severe acute respiratory syndrome Coronavirus
spring
[DOI] 10.1097/EDE.0000000000001361 PMC 바로가기 [Article Type] Article
[DOI] 10.1097/EDE.0000000000001361 PMC 바로가기 [Article Type] Article
Intensive care for seriously ill patients affected by novel coronavirus sars – CoV – 2: Experience of the Crema Hospital, Italy
신종 코로나바이러스 사스 감염 중환자 집중치료 - CoV - 2: 이탈리아 크레마 병원 경험
Article
Published on
Journal: The American journal of emergency medicine [Category] MERS, SARS, 진단, 치료기술, 치료제,
Journal: The American journal of emergency medicine [Category] MERS, SARS, 진단, 치료기술, 치료제,
[키워드] 19 outbreak
acute lung damage
Acute respiratory infection
Admission
admitted to ICU
Affect
affected
age
alterations
analyzed
Antibiotic therapy
Antiviral
appear
appearance
ARDS
assistance
available data
average
average age
barotrauma
barotrauma mechanism
bilateral pneumonia
blood chemistry
blood gas
blood gas analysis
Care
caused
cerebral hemorrhage
Chest
close contact
Comorbidities
Comorbidity
Complication
complications
condition
conditions
consecutive patient
cortisone
CoV
CoV - 2
COVID
criterion
Critical
D-dimer
death
Deceased
Department
died
disease
disease outbreak
distribution
dosage
effort
Emergency
emergency department
emergency room
Encephalitis
event
events
Evidence
experience
flu
forms
gas analysis
general condition
gold
heart disease
help
heparin
heterogeneity
heterogeneous
high mortality
Hospitalization
Hydroxychloroquine
hydroxychloroquine therapy
hypoxia
ICU
identify
IL6
impairment
Infection
intensive care
intensive care unit
Intubated
intubated patients
intubation
ischemic heart disease
Italy
lesion
lesions
less
liver
liver failure
low molecular weight
lung damage
majority
male
management
Mechanical
mechanical ventilation
mechanism
medium
moderate
monoclonal antibody
Mortality
mortality data
multi-organ failure
multiple comorbidities
multiple comorbidity
myopathies
neurological
New coronavirus
non-invasive ventilation
Novel coronavirus
occurred
Older
onset of symptom
operators
outbreak
oximetry
pandemic
parameter
Pathogens
pathology
pathway
Patient
patients
patients died
patients with SARS
phenotype
Prevalence
Prevention and control
Prognosis
Prognostic factor
Protective
protocol
protocols
recruited
recruitment
renal
renal failure
Research
resource
respiratory
respiratory distress
respiratory droplet
Respiratory droplets
respiratory infection
respiratory insufficiency
resulting
SARI
SARS
Sepsis
seriously ill patient
severe hypoxia
Severe respiratory distress
shown
sudden onset
Support
Surveillance
survival
surviving patient
surviving patients
survivor
Survivors
Symptom
syndrome
systemic disease
the timing
therapy
thromboembolic
thromboembolic complication
tracheal
Transmission
Treatment
venous
Ventilation
Viral
was performed
worsening
[DOI] 10.1016/j.ajem.2020.08.005 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.ajem.2020.08.005 PMC 바로가기 [Article Type] Article
Widespread Parenchymal Abnormalities and Pulmonary Embolism on Contrast-Enhanced CT Predict Disease Severity and Mortality in Hospitalized COVID-19 Patients
Medicine
[키워드] affecting
Analysis
Anticoagulant treatment
approach
Better
C-reactive protein
Characteristics
Clinical deterioration
clinical suspicion
cohort analysis
collected
Computed tomography
confidence interval
contributed
correlated
COVID-19
COVID-19 patient
creatinine
Critical care
CTPA
D-dimer
emboli
Embolism
examined
Factor
hemoglobin
high mortality
highest
Hospitalized
ICU
IMPROVE
Inflammation
interquartile range
intravenous
Laboratory parameters
lesion
liberal
main pulmonary artery
median age
men
Mortality
mortality data
mortality risk
MOST
outcome
parenchymal
parenchymal abnormalities
parenchymal abnormality
Patient
patients
PCR-positive patient
plasma
predict
procalcitonin
pulmonary
Pulmonary embolism
pulmonary infiltrates
Pulmonary thromboembolism
pulmonary trunk
radiological
radiologist
retrospective
severe systemic disease
severity
significantly
single-center
stratified
thromboembolic disease
tomography
Troponin-T
were recorded
widespread
women
[DOI] 10.3389/fmed.2021.666723 PMC 바로가기 [Article Type] Medicine
[DOI] 10.3389/fmed.2021.666723 PMC 바로가기 [Article Type] Medicine
The Global Case-Fatality Rate of COVID-19 Has Been Declining Since May 2020
Articles
Published on
Journal: The American Journal of Tropical Medicine and Hygi [Category] COVID-19, MERS, SARS,
Journal: The American Journal of Tropical Medicine and Hygi [Category] COVID-19, MERS, SARS,
[키워드] association
average
beta regression model
Care
collected
country
COVID-19
COVID-19 case
COVID-19 test
COVID-19 testing
cumulative
declining
decreasing
diagnose
drug
evaluate
explained
fatality
Fatality rate
Health
identify
incidence rate
Infection
management
mortality data
obesity
performed
positive
Predictive
predictor
Prevalence
Rate
rate of infection
reached
reducing
reported
shielding
shown
significantly
WHO’
younger people
[DOI] 10.4269/ajtmh.20-1496 PMC 바로가기 [Article Type] Articles
[DOI] 10.4269/ajtmh.20-1496 PMC 바로가기 [Article Type] Articles
Convalescent plasma use in the USA was inversely correlated with COVID-19 mortality
미국의 회복기 혈장 사용은 COVID-19 사망률과 반비례합니다
Research Article
[키워드] Admission
age
authority
authorization
Blood
CCP
change
convalescent plasma
correlated
COVID
COVID-19
death
deaths
declined
Department
development
drug
Drug administration
Emergency
Emergency use authorization
EUA
Evidence
examination
Expanded access
Expanded Access Program
explain
food
funding
hospital
Hospital admission
Hospital admissions
hospitalized COVID-19 patient
hospitalized COVID-19 patients
Human
Inpatient
Inpatients
inverse correlation
less
Mortality
mortality data
nadir
office
organization
pandemic
Patient
peaked
plasma
provide
Randomized controlled trial
Randomized controlled trials
reduce
reduction in mortality
research and development
robust
SARS-CoV-2 variants
Secretary
supported
therapy
US Food and Drug Administration
USA
Usage
virus infection
with COVID-19
[DOI] 10.7554/eLife.69866 PMC 바로가기 [Article Type] Research Article
[DOI] 10.7554/eLife.69866 PMC 바로가기 [Article Type] Research Article
Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech)
Commentary
[키워드] administration
adverse event
Analysis
aspiration pneumonia
association
benefit
BNT162b2
cardiovascular disease
causal link
cause
coronavirus vaccine
death
died
event
FIVE
hemorrhage
Hemorrhagic
ICH
incidence
incompatible
Japan
Japanese
men
men and women
mortality data
Pfizer-BioNTech
raised
regulatory authority
report
reported
reveal
Statistics
stroke
the vaccine
thrombosis
venous
women
[DOI] 10.1186/s40545-021-00326-7 PMC 바로가기 [Article Type] Commentary
[DOI] 10.1186/s40545-021-00326-7 PMC 바로가기 [Article Type] Commentary